What To Expect From Embla Medical hf (OCSE:EMBLA) Q3 2025 Earnings
This article first appeared on GuruFocus.
Embla Medical hf (OCSE:EMBLA) is set to release its Q3 2025 earnings on Oct 21, 2025. The consensus estimate for Q3 2025 revenue is $1.50 billion, and the earnings are expected to come in at $0.32 per share. The full year 2025's revenue is expected to be $5.93 billion and the earnings are expected to be $1.22 per share. More detailed estimate data can be found on the Forecast page.
Warning! GuruFocus has detected 1 Warning Sign with OCSE:EMBLA.
Is OCSE:EMBLA fairly valued? Test your thesis with our free DCF calculator.
Over the past 90 days, revenue estimates for Embla Medical hf (OCSE:EMBLA) have declined slightly from $5.94 billion to $5.93 billion for the full year 2025. However, for 2026, revenue estimates have increased from $6.48 billion to $6.50 billion. Earnings estimates have remained steady at $1.22 per share for the full year 2025, while for 2026, they have increased from $1.39 per share to $1.42 per share.
In the previous quarter ending on June 30, 2025, Embla Medical hf's (OCSE:EMBLA) actual revenue was $1.49 billion, which missed analysts' revenue expectations of $1.50 billion by -0.89%. Embla Medical hf's (OCSE:EMBLA) actual earnings were $0.32 per share, which met analysts' earnings expectations. After releasing the results, Embla Medical hf (OCSE:EMBLA) was up by 0.31% in one day.
Based on the one-year price targets offered by 5 analysts, the average target price for Embla Medical hf (OCSE:EMBLA) is $35.86 with a high estimate of $39.93 and a low estimate of $29.95. The average target implies an upside of 16.43% from the current price of $30.80.
Based on GuruFocus estimates, the estimated GF Value for Embla Medical hf (OCSE:EMBLA) in one year is $37.57, suggesting an upside of 21.98% from the current price of $30.80.
Based on the consensus recommendation from 5 brokerage firms, Embla Medical hf's (OCSE:EMBLA) average brokerage recommendation is currently 2.6, indicating a \\"Hold\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.